Skip to content

An Interventional Study on the Rehabilitation Effects of Virtual Reality Technology-Based Interventions for Adolescents with Depressive Disorders

An Interventional Study on the Rehabilitation Effects of Virtual Reality Technology-Based Interventions for Adolescents with Depressive Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114846
Enrollment
Unknown
Registered
2025-12-18
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorder

Interventions

Intervention group:The Intervention Group receives a 4-week VR-based combined intervention on the basis of conventional drug treatment administered to the Control Group. Basic treatment is centered on
the intervention is core to VR scenario-based interactive training, where patients are required to respond to task requirements to advance the narrative. The main forms include a progressive increase
Control group:Centered on conventional therapy with SSRIs, the dosage is adjusted to a reasonable range according to the severity of illness, with a treatment course of 4 weeks.

Sponsors

Xinxiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 10 to 19 years; 2. Diagnosed with depressive disorders by psychiatrists in accordance with the diagnostic criteria specified in the International Classification of Diseases, 10th Revision (ICD-10); 3. Undergoing stable pharmacotherapy; 4. With normal reading and writing abilities and no communication disorders; 5. Patients and their family members have provided informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. With comorbid or past history of organic brain disorders, severe traumatic brain injury, or personal/family history of epilepsy; 2. Patients with severe abnormalities of cardiac, hepatic, or renal function; 3. Patients with severe physical illness; or those with a history of substance dependence or abuse (e.g., alcohol, cocaine, or other substances); 4. With comorbid other mental illnesses, such as schizophrenia, hypomanic or manic episodes of bipolar disorder, or others; 5. With a history of motion sickness and vertigo, or presence of any active nausea or vomiting.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale Score;Children’s Depression Inventory Score;

Secondary

MeasureTime frame
Hamilton Anxiety Scale Score;Montreal Cognitive Assessment Score;Heart Rate Variability;

Countries

China

Contacts

Public ContactJunqiang Zhao

Xinxiang Medical University

021102@xxmu.edu.cn+86 135 9866 9673

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 9, 2026